COMMUNIQUÉS West-GlobeNewswire

ClearPoint Neuro Announces Pricing of Public Offering of 2,307,694 Shares of Common Stock
29/02/2024
SOLANA BEACH, Calif., Feb. 29, 2024 (GLOBE NEWSWIRE) -- ClearPoint Neuro, Inc. (Nasdaq: CLPT) (the “Company”), a global device, cell, and gene therapy-enabling company offering precise navigation to the brain and spine [...]
Achieve Life Sciences Announces Pricing of up to $124.2 Million Registered Direct Offering and Concurrent Private Placement
29/02/2024
$60 million financing upfront with up to an additional $64.2 million tied to exercise of milestone-driven warrants Upfront net proceeds to provide funds to conduct clinical development of cytisinicline through New Drug [...]
Akero Therapeutics to Present Topline Week 96 Results from Phase 2b HARMONY Study Investigating Efruxifermin in Patients with Pre-Cirrhotic MASH
29/02/2024
Investor webcast on Monday, March 4 at 8:00 a.m. ET to present clinical data SOUTH SAN FRANCISCO, Calif., Feb. 29, 2024 (GLOBE NEWSWIRE) -- Akero Therapeutics, Inc. (Nasdaq: AKRO), a clinical-stage company developing [...]
VYNE Reports 2023 Fourth Quarter and Year-End Financial Results and Provides Business Update
29/02/2024
2023 was a transformative year for VYNE, marked by the achievement of clinical proof-of-concept for VYN201 in vitiligo and a successful financing with a syndicate of leading institutional investors Anticipate commencing [...]
Recce Pharmaceuticals Continues Strategic Partnership with Murdoch Children’s Research Institute
29/02/2024
SYDNEY, Australia, Feb. 29, 2024 (GLOBE NEWSWIRE) -- Recce Pharmaceuticals Ltd (ASX: RCE, FSE: R9Q), (the Company), the Company developing a new class of synthetic anti-infectives, today announced the continuation of [...]
Compass Therapeutics to Participate in the Leerink Partners Global Biopharma Conference
29/02/2024
BOSTON, Feb. 29, 2024 (GLOBE NEWSWIRE) -- Compass Therapeutics, Inc. (Nasdaq: CMPX), a clinical-stage, oncology-focused biopharmaceutical company developing proprietary antibody-based therapeutics to treat multiple [...]
Alimera Sciences to Report Fourth Quarter and Full Year 2023 Financial Results on March 7, 2024, and Provide Corporate Update
29/02/2024
Conference Call to be held the same day at 9:00am Eastern Time ATLANTA, Feb. 29, 2024 (GLOBE NEWSWIRE) -- Alimera Sciences, Inc. (Nasdaq: ALIM) (Alimera), a global pharmaceutical company whose mission is to be [...]
OneMedNet Signs New Network Partnership Agreement with One of the Largest Private Hospital Operators in U.S.
29/02/2024
~ Partnership Will Significantly Expand Depth and Diversity of Real World Data Availability for Life Science Innovation ~ MINNEAPOLIS, Feb. 29, 2024 (GLOBE NEWSWIRE) -- OneMedNet Corporation (Nasdaq: ONMD) (“OneMedNet” [...]
Viracta Therapeutics Announces Completion of Second-Stage Enrollment into the Peripheral T-Cell Lymphoma Cohort of the NAVAL-1 Trial
29/02/2024
Accelerated pace of enrollment supports speed to market strategy Topline results from Stage 1 expected to be presented in the second quarter of 2024 followed by Stage 2 data in the third quarter of 2024 SAN DIEGO, Feb. [...]
Tonix Pharmaceuticals Announces Presentation at The 6th International Congress on Controversies in Fibromyalgia
29/02/2024
Additional data from recently reported positive Phase 3 RESILIENT trial will be presented CHATHAM, N.J., Feb. 29, 2024 (GLOBE NEWSWIRE) -- Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP) (Tonix or the Company), a [...]
MoonLake Immunotherapeutics Reports Full Year 2023 Financial Results, Recent Business Highlights and Announces an R&D Day on March 10
29/02/2024
MoonLake Immunotherapeutics Reports Full Year 2023 Financial Results, Recent Business Highlights and Announces an R&D Day on March 10 A successful year including the announcements of positive data from two Phase 2 [...]
ZyVersa Therapeutics Generated Approximately $2.7 Million From Exercise of Warrants Following Excitement Around News That Inflammasome Inhibitors Have Potential to Effectively Treat Obesity
29/02/2024
ZyVersa is developing Inflammasome ASC Inhibitor IC 100, which is designed to inhibit formation of multiple types of inflammasomes, including NLRP3, and their associated ASC specks to attenuate initiation and [...]
Dentsply Sirona Reports Fourth Quarter and Full Year 2023 Results, Provides Full Year 2024 Outlook, Raises Dividend
29/02/2024
FY23 net sales of $3,965 million increased 1.1% , organic sales increased 2.2% FY23 GAAP net income ( loss ) of ($132) million or ($0.62) per share, adjusted EPS of $1.83 Q4 net sales of $1,012 million increased 2.9% , [...]
Medigene Presents at CAR-TCR Summit Europe Showcasing Unique Approach for Development of Differentiated TCR-T Therapies
29/02/2024
Multiple members of management as expert speakers including Prof. Dr. Dolores Schendel, Chief Scientific Officer of Medigene, Dr. Barbara Lösch, Head of Technology & Innovation and Dr. Kirsty Crame, Vice President, [...]
AB Science will host a live webcast on Monday March 4, 2024, from 6.30pm to 7.30pm CET
29/02/2024
PRESS RELEASE AB SCIENCE WILL HOST A LIVE WEBCAST ON MONDAY MARCH 4, 2024 FROM 6.30PM TO 7.30PM CET Paris, 29 February, 2024, 11.30am CET AB Science SA (Euronext – FR0010557264 – AB) will host a live webcast on Monday [...]
AB Science tiendra une conférence virtuelle le lundi 4 mars 2024, de 18h30 à 19h30
29/02/2024
COMMUNIQUE DE PRESSE AB SCIENCE TIENDRA UNE CONFERENCE VIRTUELLE LE LUNDI 4 MARS 2024, DE 18H30 A 19H30 Paris, 29 février 2024, 11h30 AB Science SA (Euronext – FR0010557264 – AB) tiendra une conférence virtuelle le [...]
DONESTA® safety study for menopause completes treatment phase and advances to data management & reporting phase
29/02/2024
DONESTA ® safety study for menopause completes treatment phase and advances to data management & reporting phase Mithra on-track for completion of Phase 3 study for DONESTA ® to treat vasomotor symptoms (VMS) in [...]
Bringing confident diagnosis to more patients at low cost: Philips launches new AI-enabled CT 5300 at #ECR2024
29/02/2024
February 29, 2024 New CT 5300 system provides more accurate and reliable imaging results to better manage increase in complex cardiac cases where precise patient diagnosis is crucial Philips’ latest innovation leverages [...]
RAMSAY SANTE :half-year financial report as at end of December 2023 disposal
29/02/2024
Paris, February 29, 2024 RAMSAY SANTE Half-year Financial Report as at end of December 2023 disposal This document is available on RAMSAY SANTE Internet site : http://www.ramsaysante.fr About Ramsay Santé : Ramsay Santé [...]

Pages